Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
about
Systematic Literature Review on ICF From 2001 to 2013 in the Nordic Countries Focusing on Clinical and Rehabilitation ContextCost-effectiveness of adding magnetic resonance imaging to rheumatoid arthritis management.The personal and national costs of lost labour force participation due to arthritis: an economic study.The significance of presenteeism for the value of lost production: the case of rheumatoid arthritis.Kinematic Analysis of Gait Following Intra-articular Corticosteroid Injection into the Knee Joint with an Acute Exacerbation of ArthritisEstimating the monetary value of the annual productivity gained in patients with early rheumatoid arthritis receiving etanercept plus methotrexate: interim results from the PRIZE studyRisk factors for back pain-related loss of working time after surgery for lumbar disc herniation: a 5-year follow-up study.Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective studyWomen, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA studyThe value of early intervention in RA--a window of opportunity.Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.Rheumatoid arthritis is still expensive in the new decade: a comparison between two early RA cohorts, diagnosed 1996-98 and 2006-09.Costs for hospital care, drugs and lost work days in incident and prevalent rheumatoid arthritis: how large, and how are they distributed?Rheumatoid arthritis (RA) remains a threat to work productivity: a nationwide register-based incidence study from Finland.Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics.Modeled Health Economic Impact of a Hypothetical Certolizumab Pegol Risk-Sharing Scheme for Patients with Moderate-to-Severe Rheumatoid Arthritis in Finland.Variability in the frequency of rheumatology consultations in patients with rheumatoid arthritis in Spain.Clinical and psychosocial factors associated with depression and anxiety in Singaporean patients with rheumatoid arthritis.Work productivity loss in early arthritis during the first 3 years of disease: a study from a French National Multicenter Cohort.Use of the Stanford Health Assessment Questionnaire in estimation of long-term productivity costs in patients with recent-onset rheumatoid arthritis.Similar Improvements in Patient-Reported Outcomes Among Rheumatoid Arthritis Patients Treated with Two Different Doses of Methotrexate in Combination with Adalimumab: Results From the MUSICA Trial.Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial.
P2860
Q26775827-1C7244A1-F595-41F6-83D8-D031A4665ECEQ33717053-DF5DB775-09CE-427B-8A8B-169E2B51453CQ34604509-9F874ADB-D222-4598-A614-99F3BF5CB3BAQ35205360-DF8C1072-814F-4FE3-9FC3-751988C623A3Q35521841-DA57357F-A908-48D5-935C-7B7E688CCCF1Q36183792-8239042D-E1D6-4DB2-9F6C-6FD443DDBD7DQ36501719-A9B30A45-BE4E-460D-9C61-D3693D186BD4Q36876782-45D632C4-5F66-4BF1-890B-3906E4811CDCQ37207061-2EE762F3-257D-4810-8421-9A88AFE7D502Q37847069-AA91FD86-7BF9-4060-9CAD-C5D298ECFF03Q39888893-EAD4AFA5-1B42-491C-9253-D228C888C3E4Q40015472-8A7DE676-7CCF-4B96-9E6F-BE44548153ADQ43808737-95AE95E7-2CE1-41C6-AD02-6B18F9043F48Q44244760-E7EAB044-EC2D-4186-818B-1601A067AF8AQ45308690-FB7CBB22-1AC4-4E94-8F35-61F487CB5296Q47108715-1A22FA9D-E9B5-4368-85ED-2CBED4CB354AQ48105582-C3C482B7-5716-404E-B856-090559089019Q48915370-98B4D040-4BA4-4893-AF88-753B9E53AD2FQ50661536-861FFB0D-1AF4-4E04-BAC4-32FF573732E5Q51129676-A38620DD-4ED1-40AB-A460-1C23CE71A846Q51735403-F590DBFD-CA23-45B8-8241-219D1C3B05A6Q51906908-9B737F13-610D-4FEC-BA0B-6C4829A0FF8A
P2860
Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Monetary value of lost product ...... ience from the FIN-RACo trial.
@ast
Monetary value of lost product ...... ience from the FIN-RACo trial.
@en
type
label
Monetary value of lost product ...... ience from the FIN-RACo trial.
@ast
Monetary value of lost product ...... ience from the FIN-RACo trial.
@en
prefLabel
Monetary value of lost product ...... ience from the FIN-RACo trial.
@ast
Monetary value of lost product ...... ience from the FIN-RACo trial.
@en
P2093
P2860
P356
P1476
Monetary value of lost product ...... rience from the FIN-RACo trial
@en
P2093
FIN-RACo Trial Group
H Kautiainen
K Puolakka
M Arkela-Kautiainen
M Leirisalo-Repo
M Pekurinen
P Hannonen
R Luukkainen
P2860
P304
P356
10.1136/ARD.2005.045807
P407
P577
2005-11-16T00:00:00Z